Academies Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
Condition: Neuroendocrine Tumors Intervention: Drug: Surufatinib Combined With Temozolomide and S-1 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Study of Innovative Strategies for Mitral Valve Repair
Condition: Congenital Mitral Insufficiency Intervention: Procedure: 3-steps standardized repair-oriented strategy Sponsors: China National Center for Cardiovascular Diseases; Shanghai Children's Medical Center; Chinese Academy of Medical Sciences, Fuwai Hospital; Guangzhou Women and Children's Medical Center; Children's Hospital of Chongqing Medical University; Fuwai Central China Cardiova scular Hospital, Zhengzhou, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

Study of Innovative Drug Treatment Therapy for Pediatric Mitral Regurgitation
Condition: Congenital Mitral Insufficiency Interventions: Drug: Captopril Tablets; Drug: Metoprolol Oral Tablet; Drug: Spironolactone Tablets; Drug: Torsemide Tablets; Drug: Potassium citrate powder Sponsors: China National Center for Cardiovascular Diseases; Shanghai Children's Medical Center; Chinese Academy of Medical Sciences, Fuwai Hospital; Guangzhou Women and Children's Medical Center; Children's Hospital of Chongqing Medical University; Fuwai Central China Cardiova scular Hospital, Zhengzhou, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Conditions: Tislelizumab; Chemotherapy; First-line; Gastric Cancer Stage IV Intervention: Drug: Tislelizumab Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation
Conditions: Fluorescence; Indocyanine Green; Rectal Cancer Surgery Intervention: Device: Fluorescence laparoscopic system Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

COMPETE Cohort Study
Conditions: PFO - Patent Foramen Ovale; Migraine Intervention: Device: PFO occlusion Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials